ArticleJournal of hematology & oncology2020

Abnormally activated OPN/integrin αVβ3/FAK signalling is responsible for EGFR-TKI resistance in EGFR mutant non-small-cell lung cancer.

Yulong Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.